🕵️ Biorestorative Therapies, Inc. ($BRTX)
SEC insider & ownership activity, last 12 months · CIK 1505497 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Aug 21, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alstodt Lance | 15.5% | 13D | Feb 14, 2025 | filing ↗ | |
| Silva, Francisco | 15.1% | 13D | Feb 14, 2025 | filing ↗ | |
| Auctus Fund, LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Auctus Fund Management LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Alfred Sollami | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Louis Posner | 9.9% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Sep 2, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2026 | filing ↗ |
| Auditor change (4.01) | Aug 26, 2026 | filing ↗ |
| Other events (8.01) | Aug 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 26, 2026 | filing ↗ |
| Auditor change (4.01) | Aug 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 26, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 21, 2026 | filing ↗ |
| Other events (8.01) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 11, 2026 | filing ↗ |